Aprecia Pharmaceuticals

#CPHIFrankfurt Conference week is days away — and Aprecia is bringing the innovation! Join us for a jam-packed few days of innovation, including: Mike Gosselin’s talk on “Current and Future Applications of 3D Printing in Pharmaceutical Dosage Form Development” on Wednesday, Oct 29 at 4:10PM CET | Thermo Fisher Scientific Theatre Booth 5.1A8 Product Spotlight Presentation with Kyle Smith and Dr. Thomas Kipping: “Accelerating Innovation by combining 3D Printing and Solubility Enhancement ” featuring Parteck® SLC + Binder Jet 3DP solutions on Thursday, Oct 30 at 1:45pm CET | Hall 4.1 - 4.1L8 Feeling “Stressed about Solubility?” Stop by our booth for a giveaway, meet the team and explore our interactive ZFF model. Let us know if you’re attending — we’d love to connect: https://lnkd.in/eThBRCfk

Our innovative #3Dprinting technology enables flexible oral dosage forms with tailored release profiles and broad API compatibility. With oral tablets dominating drug delivery and FDA approval of first-in-class OSD therapies this year, the push for personalized, on-demand treatments is greater than ever. We’re proud to be leading the charge in transforming how medicine is made. Check out Aprecia’s 3DP Tablet Interactive to learn more: https://lnkd.in/gD9yzv5H #PharmaInnovation #PersonalizedMedicine #DrugDelivery #AdditiveManufacturing #OSD

🌟 Revolutionizing Drug Delivery with 3D Printing! 🌟 Check out this latest write-up 📈 featuring the combination of SoluPrint™, binder jetting 3DP using Aprecia's technology, and Parteck® SLC mesoporous silica. This collaboration showcases how advanced manufacturing and formulation science can come together to address solubility challenges and unlock new therapeutic possibilities. Grateful to our partners at Merck Life Science for highlighting this exciting work. Read more about SoluPrint™: http://bit.ly/3KE3QPr. #pharma #innovation #advancedmanufacturing #additivemanufacturing #3Dprinting #solubilityenhancement

The countdown to #CPHIFrankfurt is on — and we couldn’t be more excited. This year, Aprecia will be sharing more about our 3D printing capabilities. First up, join our very own Mike Gosselin, Vice President of Pharmaceutical Development, where he will be discussing Aprecia’s emerging and disruptive technologies at “Current & Future Applications of 3D Printing in Pharmaceutical Dosage Form Development” on Wednesday, October 29 at 4:10PM CET at the Thermo Fisher Scientific Theatre Hall 5.1A8. Then, join our President & Chief Operating Officer, Kyle Smith and Merck KGaA’s Associate Director, Head of Enabling Technologies, Dr. Thomas Kipping on Thursday, October 30, at 1:45PM at Hall 4.1 - 4.1L8 for our Product Innovation Spotlight Presentation. Discover how SoluPrint™, binder jetting 3DP powered by Aprecia technology, and Parteck® SLC mesoporous silica are shaping the future of pharma. Have questions about formulation innovation or 3DP-enabled scalability? Schedule a meeting with us: http://bit.ly/4nSRYrk

The race to develop next-generation treatments is accelerating — but the real breakthrough lies in how they’re formulated. Aprecia’s 3D printing technology enables rapid development, precise dosing, and scalable production for complex oral medications. As the industry shifts from injectables to pills, our expertise in additive manufacturing and formulation design can help partners up-level their products and bring new solutions to patients faster. Want to learn how Aprecia can support your next breakthrough in oral medication? 👉 Connect with us or visit https://aprecia.com/about/ for partnership opportunities. #PharmaInnovation #3DPrintingTechnology #OralFormulations #Aprecia #ObesityTreatment #GLP1

We look forward to attending Discovery & Development by Oxford Global's Formulation & Delivery US 2025 in San Deigo this week. We're focused on imagining new possibilities in the digital age of medicine – come learn about our proprietary three-dimensional printing (3DP) technology platforms that are transforming pharmaceutical manufacturing technology capabilities. Join Michael Gosselin, where he will be presenting "3D Printing for the Development and Manufacturing of Novel Pharmaceutical Dosage Forms". Let’s meet at #DiscoveryDevelopment25 to discuss solutions never thought possible. Reach out to our team now! #medicinereimagined #3Dprintingtechnology #pharmaceuticaltechnology